Viewing Study NCT04017832


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-01-01 @ 1:52 PM
Study NCT ID: NCT04017832
Status: COMPLETED
Last Update Posted: 2024-10-01
First Post: 2019-07-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-07-29
Start Date Type: ACTUAL
Primary Completion Date: 2021-10-27
Primary Completion Date Type: ACTUAL
Completion Date: 2021-10-27
Completion Date Type: ACTUAL
First Submit Date: 2019-07-11
First Submit QC Date: None
Study First Post Date: 2019-07-12
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-10-26
Results First Submit QC Date: None
Results First Post Date: 2023-09-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-27
Last Update Post Date: 2024-10-01
Last Update Post Date Type: ACTUAL